Supporting the designation of September 2025 as "National Ovarian Cancer Awareness Month".
- Bill Number
- H.Res. 775
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-09-30: Referred to the House Committee on Oversight and Government Reform.
- Last Updated
- 2025-11-26T16:07:30Z
AI-Generated Summary
Purpose
This House Resolution (H. Res. 775) aims to support the designation of September 2025 as "National Ovarian Cancer Awareness Month." It seeks to raise public awareness about ovarian cancer, including its symptoms, risks, disparities in diagnosis and treatment, and the need for more research and education.
Key Provisions
- Support for Designation: The House of Representatives expresses support for naming September 2025 as "National Ovarian Cancer Awareness Month."
- Endorsement of Goals: It backs the ideals of the awareness month, which include educating the public and healthcare providers on ovarian cancer symptoms (e.g., bloating, pelvic pain, difficulty eating), risk factors (e.g., family history, BRCA gene changes), and the importance of early detection and genetic testing.
- Recognition of Facts: The resolution highlights statistics on ovarian cancer incidence (about 20,890 new cases in 2025), mortality (12,730 deaths), survival rates (51.6% overall, over 90% if caught early), and challenges like the lack of reliable early detection tests and vague symptoms leading to late diagnoses in 80% of cases.
- Addressing Disparities: It notes higher risks and poorer outcomes for Black women, women of color, low-income individuals, rural residents, and active-duty servicewomen under 45.
- Call for Action: Emphasizes the need for better data collection, increased federal research funding, genetic counseling compliance, and events by organizations like the Ovarian Cancer Research Alliance.
Significant Changes to Existing Law
This is a non-binding resolution, so it introduces no changes to existing laws or regulations. It serves as a symbolic statement of congressional support rather than enacting new policies or mandates.
Potential Impacts
- On Citizens: Could increase public knowledge of ovarian cancer symptoms and risks, potentially leading to earlier diagnoses, better access to genetic testing, and reduced mortality, especially for high-risk or underserved groups. It may encourage women to discuss family history during routine medical visits and consider preventive measures like salpingectomy (surgical removal of the fallopian tubes to lower risk).
- On Government Agencies: May indirectly prompt agencies like the National Cancer Institute to prioritize ovarian cancer research and data reporting, though no direct funding or requirements are imposed.
- On International Relations: No impacts, as the resolution is focused on domestic U.S. health awareness.
Main Stakeholders Affected
- Women and Families: Particularly those at higher risk due to genetics, family history, or demographics (e.g., Black women, low-income or rural women, active-duty servicewomen).
- Healthcare Providers: Encouraged to improve symptom recognition, genetic counseling, and adherence to treatment guidelines from organizations like the National Comprehensive Cancer Network.
- Researchers and Medical Experts: Benefits from calls for increased federal funding to address knowledge gaps in ovarian cancer.
- Advocacy Organizations: Groups like the Ovarian Cancer Research Alliance gain visibility for their awareness events and efforts to support underserved communities.
- Marginalized Populations: Underserved groups facing barriers to quality care, such as women of color and those in rural areas, who may see improved policy focus on their needs.
Notable Legal, Constitutional, or Political Implications
- Legal/Constitutional: None significant, as this is a simple resolution without the force of law. It does not infringe on rights or require action, aligning with Congress's power to express support for public health initiatives under Article I of the U.S. Constitution.
- Political: Demonstrates bipartisan support (introduced by Reps. DeLauro and Bacon) for women's health issues, potentially influencing future funding debates or awareness campaigns. It highlights health disparities, which could shape political discourse on equity in healthcare without creating enforceable obligations.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. DeLauro, Rosa L. [D-CT-3]
Cosponsors (1)
Recent Actions
- 2025-09-30: Referred to the House Committee on Oversight and Government Reform.
- 2025-09-30: Submitted in House
- 2025-09-30: Submitted in House
Bill Versions
- Supporting the designation of September 2025 as "National Ovarian Cancer Awareness Month". — issued 2025-09-30 — PDF (5 pages)